Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Kool

Showing results (231-240 of 318) with videos related to

Pageof 32
Sort By:
Cancer Cell|September 12, 2018
Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma SubgroupsTenley C Archer, Tobias Ehrenberger, Filip Mundt, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 16, 2026
Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade gliomaLisa Mayr, Leah Mager, Lisa Gabler-Pamer, et al.
Nature Communications|September 4, 2019
YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesisKristian W Pajtler, Yiju Wei, Konstantin Okonechnikov, et al.
Nature Communications|March 13, 2020
An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneityCamilla Calandrini, Frans Schutgens, Rurika Oka, et al.
Acta Neuropathologica|February 23, 2021
Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus studyAnthony P Y Liu, Bryan K Li, Elke Pfaff, et al.
Cancer Cell|February 12, 2015
Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumorsJenny Wegert, Naveed Ishaque, Romina Vardapour, et al.
Cell|October 22, 2013
Hypermutation of the inactive X chromosome is a frequent event in cancerNatalie Jäger, Matthias Schlesner, David T W Jones, et al.
Oncotarget|September 18, 2015
Non-random aneuploidy specifies subgroups of pilocytic astrocytoma and correlates with older ageAdam M Fontebasso, Margret Shirinian, Dong-Anh Khuong-Quang, et al.
Acta Neuropathologica|February 14, 2013
Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutationsDavid E Reuss, Rosario M Piro, David T W Jones, et al.
Cell Reports|November 12, 2019
Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell InfiltrationHye-Jung E Chun, Pascal D Johann, Katy Milne, et al.
Pageof 32

Showing results (231-240 of 318) with videos related to

Sort By:
Pageof 32
Cancer Cell|September 12, 2018
Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma SubgroupsTenley C Archer, Tobias Ehrenberger, Filip Mundt, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 16, 2026
Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade gliomaLisa Mayr, Leah Mager, Lisa Gabler-Pamer, et al.
Nature Communications|September 4, 2019
YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesisKristian W Pajtler, Yiju Wei, Konstantin Okonechnikov, et al.
Nature Communications|March 13, 2020
An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneityCamilla Calandrini, Frans Schutgens, Rurika Oka, et al.
Acta Neuropathologica|February 23, 2021
Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus studyAnthony P Y Liu, Bryan K Li, Elke Pfaff, et al.
Cancer Cell|February 12, 2015
Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumorsJenny Wegert, Naveed Ishaque, Romina Vardapour, et al.
Cell|October 22, 2013
Hypermutation of the inactive X chromosome is a frequent event in cancerNatalie Jäger, Matthias Schlesner, David T W Jones, et al.
Oncotarget|September 18, 2015
Non-random aneuploidy specifies subgroups of pilocytic astrocytoma and correlates with older ageAdam M Fontebasso, Margret Shirinian, Dong-Anh Khuong-Quang, et al.
Acta Neuropathologica|February 14, 2013
Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutationsDavid E Reuss, Rosario M Piro, David T W Jones, et al.
Cell Reports|November 12, 2019
Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell InfiltrationHye-Jung E Chun, Pascal D Johann, Katy Milne, et al.
Pageof 32